| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Simons JW | |
| Zhong H | |||
| Mabjeesh NJ | |||
| P433 | issue | 2 | |
| P921 | main subject | prostate cancer | Q181257 |
| gene therapy | Q213901 | ||
| P304 | page(s) | 115-139 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Endocrine-Related Cancer | Q3054004 |
| P1476 | title | Gene therapy of prostate cancer: current and future directions | |
| P478 | volume | 9 |
| Q40488102 | Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer |
| Q33677054 | Advances in preclinical investigation of prostate cancer gene therapy |
| Q35528755 | Blocking IKKα expression inhibits prostate cancer invasiveness |
| Q35214290 | Breakthroughs in cancer gene therapy |
| Q50065798 | Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B. |
| Q40008139 | Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging. |
| Q64377598 | Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer |
| Q27694606 | Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic |
| Q39740442 | Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells |
| Q34557622 | Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. |
| Q36349678 | Gene delivery and gene therapy of prostate cancer |
| Q31146315 | Gene delivery into prostate cancer cells by holmium laser application |
| Q36258513 | Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies |
| Q33911470 | Identification of a LNCaP-specific binding peptide using phage display |
| Q45873905 | Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses |
| Q40343238 | Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. |
| Q45877911 | Is gene therapy the answer for prostate cancer? |
| Q35209685 | Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokine |
| Q40441090 | Molecular aspects of prostate cancer: implications for future directions |
| Q36543076 | Novel gene-directed enzyme prodrug therapies against prostate cancer |
| Q35200626 | Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy |
| Q33647321 | Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy |
| Q27013843 | Prostate cancer relevant antigens and enzymes for targeted drug delivery |
| Q38826986 | RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice |
| Q38337299 | Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressor |
| Q36512533 | Specific targeting of gene therapy to prostate cancer using a two-step transcriptional amplification system |
| Q57492228 | Targeted nonviral gene therapy in prostate cancer |
| Q27013664 | Toxin-based therapeutic approaches |
| Q35558678 | Transcriptionally targeted gene therapy to detect and treat cancer |
| Q40409415 | Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo |
Search more.